Investment
Features
FeesSafety
Academy
More
Pluang+

Compare PACCAR Inc. Common Stock (PCAR) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

PACCAR Inc. Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

PACCAR Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? PACCAR Inc. Common Stock trades at $109.43 (market cap $57.14B), while Vir Biotechnology Inc. Common Stock trades at $10.38 (market cap $1.76B). The key difference: PACCAR Inc. Common Stock is far larger — about 32.5× Vir Biotechnology Inc. Common Stock's market cap, and PACCAR Inc. Common Stock pays a 1.29% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold PACCAR Inc. Common Stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

PCARVIR
Market Cap
$57.14B$1.76B
Volume
2,748,3102,764,948
Sector
IndustrialsHealth
52-Week High
$138.21$11.78
52-Week Low
$94.15$5.12
Typical Hold Time
6 Days0 Days
Enterprise Value
$63.00B$1.32B
Dividend Yield
1.29%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

PACCAR Inc. Common Stock

PACCAR (PCAR) trades at $107.98, down 0.14% with bearish technical signals but strong fundamentals including 9% net income margin and 12.76% ROE. Recent earnings beat expectations in Q2 2026 with $1.43 EPS versus $1.36 expected. The company maintains stable cash flows with $4.3B operating cash flow projected for 2026 and recently declared a $0.35 quarterly dividend payable December 2026.

PCAR presents a mixed outlook with Wall Street consensus price target of $134.83 suggesting 25% upside potential, though technical indicators show bearish momentum. Key risks include sector sensitivity to interest rates and industrial cyclicality, while opportunities lie in the company's strong profitability metrics and defensive non-trucking segments representing over 60% of earnings.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PCAR

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About PACCAR Inc. Common Stock

PACCAR designs and manufactures heavy-duty trucks under brands including Peterbilt, Kenworth, and DAF. It also provides parts, financial services, and technology for commercial vehicles.

Read more on PCAR →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →